Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDAź | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website

DVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1594 of 1641  at  6/9/2019 11:20:14 AM  by

fmrick


 In response to msg 1593 by  ulingt
view thread

Re: Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDAź

That is exactly the point. 
 
Each quarter they report on sales of Hepisava-B  (that are actually increasing) followed by the spending of their capital to keep cancer program going.  By selling the cancer program, they can use the revenue from sales to promote more sales and get the vaccine maximized to its full potential.
 
I'd bet that if they could sell the cancer program, use that money to pay off debt, and get sales of the vaccine up, they would be profitable within a year.  
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 130
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1595 Re: Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDAź cre8profit 0 6/9/2019 9:24:02 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...